SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-I - Tender offer statement by Issuer:
SEC Accession No. 0001493152-17-013521
Filing Date
2017-11-20
Accepted
2017-11-20 06:16:21
Documents
16

Document Format Files

Seq Description Document Type Size
1 sctoi.htm SC TO-I 194522
2 exa1a.htm EX-99.(A)(1)(A) 415853
3 exa1b.htm EX-99.(A)(1)(B) 211083
4 exa1c.htm EX-99.(A)(1)(C) 23357
5 exa1d.htm EX-99.(A)(1)(D) 10492
6 exa1e.htm EX-99.(A)(1)(E) 26609
7 exa1f.htm EX-99.(A)(1)(F) 9605
8 image_001.jpg GRAPHIC 5212
9 image_002.jpg GRAPHIC 6796
10 image_005.jpg GRAPHIC 3357
11 image_007.jpg GRAPHIC 5596
12 image_008.jpg GRAPHIC 2566
13 image_010.jpg GRAPHIC 2566
14 image_011.jpg GRAPHIC 5902
15 image_012.jpg GRAPHIC 2937
16 image_013.jpg GRAPHIC 38152
  Complete submission text file 0001493152-17-013521.txt   994958
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filed by) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I
SIC: 2834 Pharmaceutical Preparations

Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Subject) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I | Act: 34 | File No.: 005-84809 | Film No.: 171212575
SIC: 2834 Pharmaceutical Preparations